ISPO

cancer susceptibility

Avoidable cancer risk factors

J Huff PhD

Altered expression of p53: biological and clinical implications

T Soussi PhD

Regulation of proteasomal degradation of the cell cycle inhibitor p27 and the prognostic significance of p27 and Skp2 in human cancers

JM Slingerland

Hereditary colorectal cancer: genetic testing, chemoprevention, and clinical management

PM Lynch MD

Telomerase: A cancer chemopreventive and therapeutic target

JW Shay PhD